© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Kathy LaTour is a breast cancer survivor, author of The Breast Cancer Companion and co-founder of CURE magazine. While cancer did not take her life, she has given it willingly to educate, empower and enlighten the newly diagnosed and those who care for them.
Drugs have more than one name, which can be confusing for cancer patients.
Drugs have more than one name, which can be confusing for patients. When a drug is in development, it is classified by how it works. For example, in this story, one of the similarities of the drugs in the taxane class is that they all cause neuropathy (other drugs mentioned in this article are listed below).
Every drug is assigned a generic name by the Food and Drug Administration (FDA) that remains with the drug regardless of how it is later marketed by the manufacturer. For example, paclitaxel is the generic name for Taxol, and docetaxel is the generic name for Taxotere. The brand name of a drug is determined by the drug’s developer and is used exclusively while the patent is in effect. As that time nears expiration, other manufacturers can apply to the FDA to make and sell generic versions of the drug. CURE uses a drug’s brand name, followed by its generic name, as long as the drug is under patent, and refers to the drug’s generic name only when the patent has expired or before a patent is granted.
Here are the generic and brand names of certain drugs:
gabapentin - Neurontin
paclitaxel - Taxol
docetaxel - Taxotere
duloxetine - Cymbalta
bortezomib - Velcade
cyclophosphamide - Cytoxan
pregabalin - Lyrica
oxycodone - Oxycontin
lenalidomide - Revlimid
pomalidomide - Pomalyst
Related Content: